ZLAB241220P50000
- 0.00
- 0.000.00%
Zai Lab Newsroom
Zai Lab Announces Participation in Investor Conference in January 2025
China to Lift Fiscal Spending to Boost Economy
China Central Economic Work Conference: A Key Indicator for Future Market Trends
Tonight, Chinese concepts soared! The nasdaq Golden Dragon index surged by 10%, while fangdd network doubled directly.
Some analysis indicates that the Political Bureau meeting first mentioned stabilizing the stock and real estate markets, and the US stock market quickly rallied on china assets. The 3x Long FTSE china etf surged over 26%, the 2x Long china internet plus-related stocks rose over 22%, the 2x Long FTSE china 50 ETF increased over 17%, and the 2x Long 300etf gained nearly 15%.
China Will Adopt a "Moderately Accommodative" Monetary Policy in the Next Year, The First Shift to Easing Since 2011
Express News | China Signals Major Policy Shift: Hang Seng and Chinese Stocks Rally on Easing Measures
The U.S. bioterrorism law has undergone significant changes, the CRO concept has launched a major counterattack, and WuXi AppTec is excited!
Industry pessimistic expectations may improve.
How to break through the challenges in the development of innovative drugs? The industry suggests focusing on internationalization.
① The year 2024 will be the inaugural year of large-scale authorized trade, and going abroad has become an important direction for the development of local pharmaceutical companies; ② Chinese企业品牌, clinical trial capabilities, data presentation formats, and levels of international operation still need time and practical verification.
Asian Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading
Zai Lab Ltd Issues Restricted Share Units to Employees
Hong Kong stock abnormal | zai lab (09688) rose more than 4%, tumor electric field treatment of pancreatic cancer ushered in a breakthrough, positive main results of phase 3 PANOVA-3 study.
zai lab (09688) rose more than 4%, as of the time of publication, it rose by 4.67%, to 23.55 Hong Kong dollars, with a turnover of 16.0669 million Hong Kong dollars.
NovoCure's Tumor-Treating Electric Fields Shows Promise In Pancreatic Cancer Patients
Sector Update: Health Care Stocks Mixed Pre-Bell Monday
Exchange-Traded Funds, Equity Futures Mixed Pre-Bell Monday Ahead of Week Promising Crucial Economic Data
Zai Lab, NovoCure Say Pancreatic Cancer Trial Meets Primary Endpoint
Express News | Zai Lab and Novocure Announce Positive Topline Results From Phase 3 Panova-3 Clinical Trial of Tumor Treating Fields (Ttfields) Therapy for Pancreatic Cancer
Reported Wednesday, Zai Lab Announces AUGTYRO Inclusion For ROS1+ NSCLC In China's Updated National Reimbursement Drug List
Zai Lab's AUGTYRO For ROS1+ NSCLC Added To China's National Reimbursement Drug List
Express News | Zai Lab Announces the Inclusion of Augtyro® (Repotrectinib) for Ros1+ Nsclc and Other Updates in China’s National Reimbursement Drug List
Asian Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading